GeneBio and Goodlett Laboratory Launch Collaboration

Geneva, Switzerland and Seattle, Washington, USA - October 19, 2006 - Geneva Bioinformatics (GeneBio) SA and the Goodlett Laboratory of the University of Washington today announced a collaboration that will integrate GeneBio's Phenyx software platform for MS data analysis into the Goodlett Laboratory's planned 200 node Multi-tiered Proteomics Compute (MPC) cluster. GeneBio and the Goodlett Laboratory have already begun working together to enhance Phenyx's operation on the Laboratory's existing 40 node MPC, and the Laboratory expects to use Phenyx as their primary proteomics analysis engine. Phenyx-generated identifications will be vetted by the Insilicos Proteomics Pipeline, a tool supported through collaboration between Insilicos and GeneBio.

Established in 2004, the Goodlett Laboratory is a world leader in the field of mass spectrometry and currently uses a 40-node cluster to identify proteins from peptide tandem mass spectra for a diverse set of scientific applications. Phenyx is a software platform for the identification and characterization of proteins and peptides from mass spectrometry data. The platform is designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment.

Dr. David R. Goodlett, Associate Professor of Medicinal Chemistry at the University of Washington announced "We are excited about this collaboration and will use it as a starting point to further refine and develop our MS workflow. The Lab and GeneBio plan to work together on scientific projects of mutual interest; our own internal developments will go hand-in-hand with special developments on Phenyx to optimally adapt it to these projects, one of which includes running protein de novo folding software combined with MS/MS data interpretation. So, we expect this to be an extremely fruitful relationship."

"This partnership with the Goodlett Laboratory really shows with how much efficiency Phenyx has been fulfilling high proteomics expectations since its introduction in 2004," said Prof. Ron D. Appel, PhD, Chairman and Scientific Founder of GeneBio and head of the Proteome Informatics Group at the Swiss Institute of Bioinformatics. "The results of our work together, including new scorings, feature ameliorations, and new developments in the field of proteomics will be used to further refine both the public and commercial versions of Phenyx, thus cementing our standing in the realm of MS search engines. A collaborative relationship with such a world-renowned laboratory is destined to produce some exciting results; I believe this will work out well for both GeneBio and the Goodlett Laboratory."

About GeneBio
Geneva Bioinformatics (GeneBio) SA is a leading bioinformatics company providing the life science community with world-class proteomics software that bridges the gap between information gathering and knowledge generation. Established in 1997, we focus our expertise on protein identification and characterization as well as proteome imaging, offering clients and partners a high degree of specialization essential to proteomics research. Close ties to academic peers and a thorough network of distribution and strategic partners give us both unfettered access to scientific excellence and recognized market presence so that we may best serve the scientific community. For more information about GeneBio, please visit: www.genebio.com.

About the Goodlett Laboratory, Dept. of Medicinal Chemistry, University of Washington
The Goodlett Laboratory is a bioanalytical laboratory that develops separation science and mass spectrometric methods to solve biological problems. Their primary tool is mass spectrometry and specifically Fourier transform ion cyclotron resonance mass spectrometry (FTICRMS). For more information about the Goodlett Laboratory, please visit: http://goodlab.mchem.washington.edu/.

GeneBio contact:
Andrew Smith
andrew.smith@genebio.com
Tel. +41.22.702.99.00

Goodlett Laboratory contact:
Dave Goodlett
goodlett@u.washington.edu
Tel. (206) 616.4582

< back